Skip to main content
logo
Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
25.86
+0.94 (3.77%)
Aug 19, 2026, 4:00 PM EDT - Market closed

Bicara Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-185.36-137.95-68-51.99-37.85
Depreciation & Amortization
0.160.110.060.020.01
Asset Writedown & Restructuring Costs
---0.57-
Loss (Gain) From Sale of Investments
0.880.3---
Stock-Based Compensation
22.1615.017.41.90.81
Other Operating Activities
1.10.9-0.0813.5-
Change in Accounts Payable
26.1610.462.64-8.665.87
Change in Other Net Operating Assets
0.074.35-16.77-0.96-0.92
Operating Cash Flow
-134.85-106.83-74.75-45.63-32.08
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-0.4-0.28-0.07-0.59-0.19
Sale of Property, Plant & Equipment
--0.06--
Investment in Securities
-402.1-318.17---
Investing Cash Flow
-402.5-318.45-0.01-0.59-0.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Issuance of Common Stock
197.3432.26334.030.150.16
Financing Cash Flow
197.3432.26334.03272.531.7

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
-340.01-393.03259.27226.28-0.57

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-135.25-107.11-74.82-46.21-32.27
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-2.27-1.96-4.45-79.66-75.20
Levered Free Cash Flow
-76.95-66.4-53.72-32.5-
Unlevered Free Cash Flow
-76.95-66.4-53.72-32.5-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Income Tax Paid
0.03---0
Change in Working Capital
26.2314.81-14.13-9.624.95
SEC Filings: 10-K · 10-Q